This weekend, celebrate 4/20 by treating yourself to some of the best CBD wellness products around.

If you have tried everything — from sublingual drops to CBD-infused seltzer — and you haven’t found quite the right CBD product for you, don’t despair. Creative entrepreneurs are coming up with new CBD products all the time.

The FDA made a few headlines this week with respect to CBD. First, the agency announced a public hearing which will take place on May 31, 2019.

CBD advocates in Ohio are following the progress of a bill that would establish and regulate hemp cultivation and processing in the state, while also clearly legalizing CBD.

If you stopped by your local CVS in the last week, you might have noticed a new type of product on the shelves.

South Dakota Governor Kristi Noem dashed the hopes of hemp advocates this week when she vetoed a bill that would have created an industrial hemp program in the state. The state’s House of Representatives attempted to override the veto, but were unable to get the votes necessary to do so.

On Wednesday, FDA commissioner Scott Gottlieb announced his resignation, citing the toll the job takes on family life. The resignation could be a setback for the CBD industry, which is eagerly awaiting clarification from the FDA on how CBD will be regulated in the future.

In this week’s most dramatic CBD-related story, PotNetwork News published an explosive piece about a company which claimed to have isolated CBD from hops.

Twelve members of Congress sent a letter to the head of the FDA this week, asking for the agency to release updated guidance on CBD for food, drugs, and cosmetics. The lawmakers demanded a response by the end of the week, but as of this writing, the FDA has not

This week, the US Hemp Roundtable launched an online State Action Center. This interactive tool will make it easier for hemp and CBD advocates to keep up to date on hemp-related issues, and helps visitors to contact their state legislators directly. Thanks to a newly announced deal between Simon Property